Tag: Biotech and Pharmaceuticals
-
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
The Trump administration has expanded access to nicotine products despite concerns from public health critics about youth use and addiction.
-
Medicare will start covering obesity drugs for the first time. Here’s what patients should know
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
-
French biotech stock soars 25% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
-
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
-
America can’t get enough of protein. The dairy industry can’t keep up
Demand for whey protein is off the charts as American diet trends change and GLP-1s boom, and the dairy industry is struggling to produce enough.
-
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the government or Eli Lilly and Novo.
-
Estrogen patches are hard to find, and it may not be resolved any time soon
Estrogen patches are in short supply as demand for menopause treatments skyrockets, and it could take at least a year for manufacturers to catch up.
-
Chan Zuckerberg Initiative’s Biohub to open new rare disease funding round
Chan Zuckerberg Initiative’s Biohub will offer new grants to the rare disease community while expanding its AI drug repurposing partnership with Every Cure.
-
This life sciences stock has a secret weapon, and AI will only make it more valuable
IQVIA controls one of the world’s largest databases of healthcare information that’s closely integrated the clinical research process.
-
Zealand Pharma stock suffered its two worst days on record. Here’s what’s next for the weight loss drugmaker
While the market’s enthusiasm for one of Zealand’s experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news china cup Donald J. Trump Donald Trump economy European Union fast football France germany Heatwave Investment strategy iran Iran war markets news People per politics return russia said Singapore spain Sport Stock markets technology trump ukraine United Kingdom United States US-Israel attack on Iran 2026 video War in Ukraine World world cup World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
